NEUTROPENIA
Clinical trials for NEUTROPENIA explained in plain language.
Never miss a new study
Get alerted when new NEUTROPENIA trials appear
Sign up with your email to follow new studies for NEUTROPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare immune disorder: drug that mobilizes white blood cells enters trial
Disease control Recruiting nowThis study tests whether Mozobil, a drug already used in stem cell transplants, can safely and effectively raise white blood cell counts in people with WHIMS, a rare genetic condition that causes frequent infections. About 20 adults aged 18 to 75 with WHIMS and a history of sever…
Matched conditions: NEUTROPENIA
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 26, 2026 08:41 UTC
-
New drug aims to cut infections in rare immune disorder
Disease control Recruiting nowThis study tests a drug called mavorixafor in people with chronic neutropenia, a condition where the body doesn't make enough white blood cells, leading to repeated or serious infections. The goal is to see if the drug can raise white blood cell counts and lower the number of inf…
Matched conditions: NEUTROPENIA
Phase: PHASE3 • Sponsor: X4 Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
Can a drug boost blood cells and delay cancer in people with CCUS?
Disease control Recruiting nowThis study tests the drug luspatercept in 50 adults with clonal cytopenias of uncertain significance (CCUS), a condition where blood cell counts are low and there is a risk of developing blood cancer. Participants receive injections every three weeks for up to 48 weeks. The goal …
Matched conditions: NEUTROPENIA
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated May 18, 2026 12:13 UTC
-
New shot aims to stop dangerous infection risk in cancer patients
Prevention Recruiting nowThis study looks at whether a medicine called mecapegfilgrastim can help prevent neutropenia (dangerously low white blood cells) in cancer patients after chemotherapy, radiation, or immunotherapy. About 200 adults with solid tumors will receive the injection to see if it reduces …
Matched conditions: NEUTROPENIA
Sponsor: Hebei Medical University Fourth Hospital • Aim: Prevention
Last updated May 11, 2026 20:49 UTC
-
Blood cancer patients sought for Pain-Free breakthrough trial
Symptom relief Recruiting nowThis study compares two oral medications—diosmin-hesperidin (a plant-based supplement) and loratadine (an allergy pill)—to see which better prevents severe bone pain caused by G-CSF, a drug that boosts white blood cells in blood cancer patients. About 88 adults receiving G-CSF fo…
Matched conditions: NEUTROPENIA
Phase: NA • Sponsor: Alexandria University • Aim: Symptom relief
Last updated May 26, 2026 08:30 UTC